// App-Quantinova.ai

BSH19‐PO‐091 : Ifosfamide‐based regimens for lymphoma are safely administered in an ambulatory care setting: an audit of ifosfamide‐induced encephalopathy in a single tertiary centre

Researchers

Presenter

  • W.Y. Chan

Principal Investigators

  • K. Ardeshna

  • K. Cwynarski

  • J. Lambert

  • C. McNamara

  • S. Mohamedbhai

  • C. Roddie

  • W. Townsend

  • A. Virchis

  • R. Shah

Medical Centers

  • Haematology, University College London Hospitals

  • Department of Haematology, North Middlesex University Hospital

  • The Royal Marsden Hospital, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Oncology (ONC)

Disease

  • Encephalopathy

  • Lymphomas

  • Sarcoma

  • Solid malignancies

Biomarkers

  • Creatinine

  • Human albumin

Drug/Treatment

  • Methylthioninium chloride

  • Ifosfamide

  • Cisplatin

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved